Milan

• Phase 3 Study of ALXN1850 in Pediatric Participants with HPP Previously Treated with Asfotase Alfa Revoked
  2023-505674-15-00 5 Hypophosphatasia
• A Study of Disitamab Vedotin Alone and with Pembrolizumab in Urothelial Cancer That Expresses HER2 Not authorised
  2022-500030-28-00 4 Urothelial carcinoma
• A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/ … Not authorised
  2022-500410-26-00 5 Cystic Fibrosis
• ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Not authorised
  2022-500535-36-00 5 Moderately to severely active ulcerative colitis
• ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Not authorised
  2022-500536-11-00 5 Moderately to severely active ulcerative colitis
• ABTECT-Maintenance – ABX464 Treatment Evaluation for ulcerative Colitis Therapy Not authorised
  2022-500537-84-00 5 Moderately to severely active ulcerative colitis
• Clinical trial of MK-7648A in adults and children with skin cancer Not authorised
  2022-501417-31-00 5 High-risk Resected Melanoma
• Phase 3 Study Assessing Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Orbit) Not authorised
  2022-501535-16-00 5 Atopic Dermatitis (AD)
• A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into … Not authorised
  2022-501644-15-00 4 Mild Cognitive Impairment due to Alzheimer's Disease Alzheimer's Disea
• A clinical study of people with HIV‐1 who switch their treatment to a combination of doravirine and islatravir​​ Not authorised
  2022-502079-49-00 5 HIV-1 infection
• A clinical study of people with HIV-1 who have not taken antiretroviral therapy, one group will start treatment with a combination of doravi … Not authorised
  2022-502099-22-00 5 HIV-1 Infection
• A clinical study of people with HIV-1 who received prior treatment combination of doravirine and islatravir Not authorised
  2022-502126-40-00 5 HIV-1 infection
• A clinical study of people with HIV-1 who take antiretroviral therapy and switch their treatment to a combination of doravirine and islatrav … Not authorised
  2022-502127-22-00 5 HIV-1 Infection
• A Phase IIa, Open Label Study to Evaluate the Safety of Afamelanotide in Patients with Early Parkinson's Disease Not authorised
  2022-502207-30-00 4 Parkinson's Disease
• MK-0616-013 Not authorised
  2022-502777-42-00 5 Hypercholesterolemia
• A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext … Not authorised
  2022-502877-41-00 9 Pulmonary sarcoidosis with or without extrapulmonary manifestations
• A prospective, observer-blind, randomized clinical trial to investigate and compare the clinical efficacy of Chloroprocaine 3% gel and Oxybu … Not authorised
  2023-504477-21-00 5 male/female outpatients, aged 0-17 years scheduled to undergo ocular e
• HARMONi-3 Not authorised
  2023-504989-37-00 5 Metastatic Squamous Non-small Cell Lung Cancer
• Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inh … Not authorised
  2023-505311-20-00 5 Metastatic Non-Small Cell Lung Cancer
• Metal Panel Patch Test Not authorised
  2023-507972-35-00 5 Allergic contact dermatitis Eczema
• Evaluation of the safety and efficacy of the drug AL8326 in the post-first treatment of small cell lung cancer. Not authorised
  2023-509067-24-00 4 Small Cell Lung Cancer (SCLC) patients who need ≥2nd line treatment wi
• The Chronic kidney disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect (CAPTIVATE) Not authorised
  2024-511325-67-00 5 Chronic kidney disease
• Efficacy of peri-operative dexamethasone administration in single bundle anterior cruciate ligament reconstruction: a prospective randomized … Not authorised
  2024-511559-17-00 6 Adult patients with indication of arthroscopic anterior cruciate ligam
• The additive effect of ketamine in combination with electroconvulsive stimulation (ECS) in major depressive disorder (MDD): a translational … Not authorised
  2024-512559-20-00 5 Major Depressive Disorder (MDD)

Showing 1–24 of 2,361 trials